Triple receptor-negative breast cancer: Imaging and clinical characteristics. AJR, August 2012, Vol. 199(2), p.458-464.
Krizmanich-Conniff, K.Z., et al.
http://www.ajronline.org/content/199/2/458.abstract?rss=1
The objective of our study was to retrospectively evaluate the imaging findings of patients with breast cancer negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)—so-called “triple receptor–negative cancer”—and to compare the mammographic findings and clinical characteristics of triple receptor–negative cancer with non–triple receptor–negative cancers.
